← Back to Search

Behavioral Intervention

eCEASE Program for Smoking Cessation (eCEASE Trial)

N/A

Waitlist Available

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 36 months

Awards & highlights

eCEASE Trial Summary

This trial will test whether an electronic health record system that screens for tobacco and e-cigarette use, and offers assistance from a community health navigator, is more effective than usual care in promoting smoke-free homes and cars.

Who is the study for?

This trial is for parents or legal guardians who smoke and are present at their child's healthcare visit. Participants must have smoked a cigarette or any other tobacco product in the past week and be able to speak English. They should not have been previously enrolled in this study and must have access to a telephone.Check my eligibility

What is being tested?

The study is testing an electronic health record-based approach combined with support from a community health navigator, aiming to help families quit smoking. It will compare how well this new strategy works against the usual care given for smoking cessation in pediatric settings.See study design

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience stress or discomfort when discussing smoking habits or while attempting to quit.

eCEASE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Parental combusted tobacco quit rate at 12 months

Secondary outcome measures

Incremental cost per quit of the intervention

Rates of parental institution of smoking and vaping bans in their homes and cars

Rates of parental quit attempts

+2 more

eCEASE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iEHR + NavigatorExperimental Treatment1 Intervention

Group II: Usual Care ControlActive Control1 Intervention

Usual care delivery in pediatric primary care offices.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,197,538 Total Patients Enrolled

Children's Hospital of PhiladelphiaOTHER

708 Previous Clinical Trials

8,580,486 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,932,850 Total Patients Enrolled

Media Library

iEHR + Navigator (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04974736 — N/A

Tobacco Smoking Research Study Groups: iEHR + Navigator, Usual Care Control

Tobacco Smoking Clinical Trial 2023: iEHR + Navigator Highlights & Side Effects. Trial Name: NCT04974736 — N/A

iEHR + Navigator (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04974736 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants still being accepted for this research endeavor?

"Based on info available through clinicaltrials.gov, it appears that this medical trial has reached its recruitment goals and is no longer actively searching for patients; initial postings occurred July 16th 2021 but have not been modified since November 7th 2022. Fortunately, 176 other studies are currently in the process of recruiting participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

eCEASE to Support Treatment for Parental Tobacco Use

Jonathan P. Winickoff, MD, MPH 2021. "eCEASE to Support Treatment for Parental Tobacco Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04974736.